AVANOS MEDICAL INC (AVNS) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:AVNS - US05350V1061 - Common Stock
AVNS Key Statistics, Chart & Performance
The current stock price of AVNS is 11.84 USD. In the past month the price increased by 3.59%. In the past year, price decreased by -38.2%.
AVNS Latest News, Press Relases and Analysis
AVNS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.39 | 15.50B | ||
| SOLV | SOLVENTUM CORP | 14.36 | 14.78B | ||
| ALGN | ALIGN TECHNOLOGY INC | 15.23 | 10.67B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.5 | 5.18B | ||
| LNTH | LANTHEUS HOLDINGS INC | 9.86 | 3.99B | ||
| HAE | HAEMONETICS CORP/MASS | 16.82 | 3.89B | ||
| ICUI | ICU MEDICAL INC | 18.74 | 3.68B | ||
| XRAY | DENTSPLY SIRONA INC | 7.15 | 2.25B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.03 | 1.73B | ||
| NEOG | NEOGEN CORP | 20.13 | 1.31B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.28B | ||
| EMBC | EMBECTA CORP | 4.23 | 735.22M |
Related stock screener links
About AVNS
Company Profile
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Company Info
AVANOS MEDICAL INC
5405 Windward Parkway, Suite 100 South
Alpharetta GEORGIA 30004 US
CEO: Joseph F. Woody
Employees: 2227
Phone: 18444282667
AVANOS MEDICAL INC / AVNS FAQ
Can you describe the business of AVANOS MEDICAL INC?
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company is headquartered in Alpharetta, Georgia and currently employs 2,227 full-time employees. The company went IPO on 2014-10-21. The company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. The company also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
What is the stock price of AVANOS MEDICAL INC today?
The current stock price of AVNS is 11.84 USD. The price decreased by -1.09% in the last trading session.
Does AVNS stock pay dividends?
AVNS does not pay a dividend.
What is the ChartMill technical and fundamental rating of AVNS stock?
AVNS has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
How is the market expecting AVNS stock to perform?
6 analysts have analysed AVNS and the average price target is 17.34 USD. This implies a price increase of 46.45% is expected in the next year compared to the current price of 11.84.
Should I buy AVNS stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVNS.
What is AVANOS MEDICAL INC worth?
AVANOS MEDICAL INC (AVNS) has a market capitalization of 549.38M USD. This makes AVNS a Small Cap stock.
AVNS Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AVNS. When comparing the yearly performance of all stocks, AVNS is a bad performer in the overall market: 83.47% of all stocks are doing better.
AVNS Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to AVNS. AVNS has only an average score on both its financial health and profitability.
AVNS Financial Highlights
Over the last trailing twelve months AVNS reported a non-GAAP Earnings per Share(EPS) of 1.07. The EPS decreased by -7.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -43.92% | ||
| ROE | -60.27% | ||
| Debt/Equity | 0.12 |
AVNS Forecast & Estimates
6 analysts have analysed AVNS and the average price target is 17.34 USD. This implies a price increase of 46.45% is expected in the next year compared to the current price of 11.84.
For the next year, analysts expect an EPS growth of -35.56% and a revenue growth -1.38% for AVNS